Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics
NCT02821416
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
BIOLOGICAL:
Benralizumab
OTHER:
Placebo
Sponsor
AstraZeneca